Bharat Biotech's Intranasal Vaccine Gets Nod For Phase 2/3 Trials

India's first intranasal vaccine, being developed by Bharat Biotech in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Research Assistance Council (BIRAC), on Friday got regulatory approval for Phase 2/3 trials. ....

 

Full Story